Abstract:The purpose of this study was to explore the copy number variations (CNVs) associated with miscarriage. A total of 662 specimens of aborted embryonic tissue and 54 samples from peripheral blood were collected. Next generation sequencing for CNV analysis was performed to determine the type and clinical significance of possible CNVs, and relevant medical records were collected. Autosomal trisomy, both single and multiple, was the most common abnormality (207 cases, 63.5% of abnormalities). Trisomy 16 was the most frequent single trisomy, followed by trisomy 22, trisomy 15 and trisomy 21. The rate of chromosomal abnormalities of fetuses in early pregnancy (65.4%) was higher than that of fetuses in middle pregnancy (16.4%). There were 82 pregnant women with recurrent abortion, and the embryo with pathogenic CNVs was conceived in 62 (76%) cases, while the embryo with variants of unknown significance (VUS) in 12 (15%) cases. Among the 27 couples with a history of recurrent pregnancy loss (RPL), there were 4 (14.8%) couples with CNV abnormal in both partners, 16 (59.3%) couples with CNV abnormal only in the women, and 7 (25.9%) couples with CNV abnormal only in the men. These retrospective analyses of CNV-seq results provided a reference for genetic counseling of the relationship between VUS and RPL. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study did not receive any funding ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was performed under the guidance of the Declaration of Helsinki and approved by the Ethics Committee of Zhongnan Hospital of Wuhan University (Ethics No.2023049K). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors

Characterization of Chromosomal Abnormalities in Pregnancy Losses Reveals Critical Genes and Loci for Human Early Development.

Prenatal Diagnosis of Microdeletions or Microduplications in the Proximal, Central, and Distal Regions of Chromosome 22q11.2: Ultrasound Findings and Pregnancy Outcome.

Copy Number Variation Analysis of Euploid Pregnancy Loss

Non-invasive Prenatal Testing Reveals Copy Number Variations Related to Pregnancy Complications

Analysis of potential copy-number variations and genes associated with first-trimester missed abortion

Characterization of Copy-Number Variations and Possible Candidate Genes in Recurrent Pregnancy Losses

Low-pass Genome Sequencing Reveals Associations Between Copy Number Variations and Fetal Ultrasonographic Anomalies and Soft Markers in a Cohort of 43,721 Fetuses

Chromosomal Copy Number Variations in Miscarriages and the Geneic Counseling of Recurrent Pregnancy Loss

Prevalence of Chromosomal Abnormalities Identified by Copy Number Variation Sequencing in High-Risk Pregnancies, Spontaneous Abortions, and Suspected Genetic Disorders.

Implementation of a High-Resolution Single-Nucleotide Polymorphism Array in Analyzing the Products of Conception.

Clinical Application of Single Nucleotide Polymorphism Microarray Analysis in Pregnancy Loss in Northwest China.

Clinical Application of Chromosomal Microarray Analysis in Fetuses with Congenital Heart Disease

Exome Sequencing Analysis on Products of Conception: a Cohort Study to Evaluate Clinical Utility and Genetic Etiology for Pregnancy Loss

Estimation on risk of spontaneous abortions by genomic disorders from a meta-analysis of microarray results on large case series of pregnancy losses

Novel Mutations in Genes Encoding Subcortical Maternal Complex Proteins May Cause Human Embryonic Developmental Arrest.

Low-pass Whole-Genome Sequencing in Clinical Cytogenetics: a Validated Approach.

Spectrum of Cytogenomic Abnormalities Revealed by Array Comparative Genomic Hybridization on Products of Conception Culture Failure and Normal Karyotype Samples.

Prenatal diagnosis and molecular cytogenetic characterization of fetuses with central nervous system anomalies using chromosomal microarray analysis: a seven-year single-center retrospective study

Chromosomal copy number analysis on chorionic villus samples from early spontaneous miscarriages by high throughput genetic technology

Integrative analyses of maternal plasma cell-free DNA nucleosome footprint differences reveal chromosomal aneuploidy fetuses gene expression profile

Clinical Application Of Chromosomal Microarray Analysis For The Prenatal Diagnosis Of Chromosomal Abnormalities And Copy Number Variations In Fetuses With Congenital Heart Disease (Vol 38, Pg 406, 2018)